In vitro activities of meropenem and other antimicrobial agents against British meningococcal isolates

F J Abadi1, D E Yakubu, T H Pennington

  • 1Department of Medical Microbiology, University of Aberdeen Medical School, Aberdeen, UK.

Chemotherapy
|July 8, 1999
PubMed

Insights

Meropenem demonstrates high in vitro activity against Neisseria meningitidis isolates. This finding supports further evaluation of meropenem for treating bacterial meningitis and as a meningococcal prophylactic agent.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Neisseria meningitidis is a significant cause of bacterial meningitis.
  • Emerging antibiotic resistance in meningococcal isolates necessitates ongoing surveillance and the development of new therapeutic agents.

Purpose of the Study:

  • To evaluate the in vitro activity of meropenem against British Neisseria meningitidis isolates.
  • To compare meropenem's efficacy with other common antibiotics.

Main Methods:

  • Microdilution method in Mueller-Hinton broth.
  • E test for antimicrobial susceptibility testing.
  • Tested 121 British meningococcal isolates.

Main Results:

  • Meropenem exhibited high in vitro activity against all tested Neisseria meningitidis strains.
  • Susceptibility rates varied for other antibiotics: ampicillin (88.4%), penicillin (88.4%), sulphadiazine (57.9%), and rifampicin (95%).

Conclusions:

  • Meropenem shows significant potential as a therapeutic agent for bacterial meningitis.
  • Further clinical and bacteriological evaluation of meropenem for meningococcal prophylaxis and treatment is warranted.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...